Inventor · disambiguated record
Lihua Yu
Also filed as: YU LIHUA
9 granted patents·4 pending applications·10 citations·filing 2006–2024
80Inventor score
Files withEISAI R&D MAN CO LTD11ASTRAZENECA AB1TONGJI UNIV SUZHOU INSTITUTE BIOMEDICAL RESEARCH CENTER1
Top patents by PatentIndex Score
13 records- 0186US2025135017A1Splicing modulator antibody-drug conjugates and methods of useEISAI R&D MAN CO LTD·Filed 2024·Application pending·0 cites
- 0284US11352348B2Splicing modulator antibody-drug conjugates and methods of useEISAI R&D MAN CO LTD·Filed 2020·Granted Jun 7, 2022·1 cites·25 claims
- 0384US9481669B2Pladienolide pyridine compounds and methods of useEISAI R&D MAN CO LTD·Filed 2015·Granted Nov 1, 2016·7 cites·46 claims
- 0482US10889866B2Splice variants associated with neomorphic SF3B1 mutantsEISAI R&D MAN CO LTD·Filed 2016·Granted Jan 12, 2021·2 cites·18 claims
- 0577US11945807B2Splicing modulator antibody-drug conjugates and methods of useEISAI R&D MAN CO LTD·Filed 2022·Granted Apr 2, 2024·0 cites·24 claims
- 0670US12172986B2Splicing modulator antibody-drug conjugates and methods of useEISAI R&D MAN CO LTD·Filed 2019·Granted Dec 24, 2024·0 cites·46 claims
- 0770US2024350484A1Methods of using splicing modulatorsEISAI R&D MAN CO LTD·Filed 2024·Application pending·0 cites
- 0864US11998544B2Methods of using splicing modulatorsEISAI R&D MAN CO LTD·Filed 2019·Granted Jun 4, 2024·0 cites·12 claims
- 0963US11761045B2Splice variants associated with neomorphic SF3B1 mutantsEISAI R&D MAN CO LTD·Filed 2020·Granted Sep 19, 2023·0 cites·25 claims
- 1057US2020361915A1Solid state form of pladienolide pyridine compounds and methods of useEISAI R&D MAN CO LTD·Filed 2020·Application pending·0 cites
- 1156US10745387B2Crystalline form of (2S,3S,6S,7R,10R,E)-7,10-dihydroxy-3,7-dimethyl-12-oxo-2-((R,2E,4E)-6-(piridin-2-yl)hepta-2,4-dien-2-yl)oxacyclododec-4-en-6-yl-4-methylpiperazine-1-carboxylate and methods of use thereofEISAI R&D MAN CO LTD·Filed 2016·Granted Aug 18, 2020·0 cites·26 claims
- 1248US2009312396A1Methods for cancer treatment using tak1 inhibitorsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 1344US11634496B2C-MET agonistic antibody and use thereofTONGJI UNIV SUZHOU INSTITUTE BIOMEDICAL RESEARCH CENTER·Filed 2018·Granted Apr 25, 2023·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Lihua Yu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →